Type A botulinum neurotoxin complex proteins differentially modulate host response of neuronal cells

Toxicon ◽

10.1016/j.toxicon.2014.02.004 ◽

2014 ◽

Vol 82 ◽

pp. 52-60 ◽

Author(s):

Lei Wang ◽

Yi Sun ◽

Weiping Yang ◽

Paul Lindo ◽

Bal Ram Singh

Keyword(s):

Host Response ◽

Botulinum Neurotoxin ◽

Neuronal Cells ◽

Type A ◽

Neurotoxin Complex

Download Full-text

Complete DNA sequences of the botulinum neurotoxin complex of Clostridium botulinum type A-Hall (Allergan) strain

Gene ◽

10.1016/s0378-1119(03)00792-3 ◽

2003 ◽

Vol 315 ◽

pp. 21-32 ◽

Author(s):

Li Zhang ◽

Wei-Jen Lin ◽

Shengwen Li ◽

K.Roger Aoki

Keyword(s):

Dna Sequences ◽

Clostridium Botulinum ◽

Botulinum Neurotoxin ◽

Type A ◽

Botulinum Type ◽

Neurotoxin Complex

Download Full-text

Separation of the components of type A botulinum neurotoxin complex by electrophoresis

Toxicon ◽

10.1016/s0041-0101(02)00309-4 ◽

2003 ◽

Vol 41 (3) ◽

pp. 321-331 ◽

Author(s):

S.K Sharma ◽

M.A Ramzan ◽

B.R Singh

Keyword(s):

Botulinum Neurotoxin ◽

Type A ◽

Neurotoxin Complex

Download Full-text

Corrigendum to “Complete DNA sequences of the botulinum neurotoxin complex of Clostridium botolinum type A-Hall (Allergan) strain” [Gene 315 (2002) 21–32]

Gene ◽

10.1016/j.gene.2003.09.024 ◽

2003 ◽

Vol 322 ◽

pp. 187

Author(s):

Li Zhang ◽

Wei-Jen Lin ◽

Shengwen Li ◽

K.Roger Aoki'

Keyword(s):

Dna Sequences ◽

Botulinum Neurotoxin ◽

Type A ◽

Neurotoxin Complex

Download Full-text

Hemagglutinin-33 of type A botulinum neurotoxin complex binds with synaptotagmin II

FEBS Journal ◽

10.1111/j.1742-4658.2005.04688.x ◽

2005 ◽

Vol 272 (11) ◽

pp. 2717-2726 ◽

Author(s):

Yu Zhou ◽

Sean Foss ◽

Paul Lindo ◽

Hemanta Sarkar ◽

Bal Ram Singh

Keyword(s):

Botulinum Neurotoxin ◽

Type A ◽

Neurotoxin Complex

Download Full-text

134. Potency assay for botulinum neurotoxin type A based on neuronal cells as a replacement for the mouse bioassay

Toxicon ◽

10.1016/j.toxicon.2014.11.137 ◽

2015 ◽

Vol 93 ◽

pp. S41-S42 ◽

Author(s):

Gerd Mander ◽

Cornelia Bruenn ◽

Claudia Jatzke ◽

Karl-Heinz Eisele ◽

Harold V. Taylor ◽

...

Keyword(s):

Botulinum Neurotoxin ◽

Neuronal Cells ◽

Type A ◽

Mouse Bioassay ◽

Potency Assay ◽

Botulinum Neurotoxin Type A

Download Full-text

Faculty Opinions recommendation of In the human urothelium and suburothelium, intradetrusor botulinum neurotoxin type A does not induce apoptosis: preliminary results.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1718956.1228054 ◽

2010 ◽

Author(s):

JLH Ruud Bosch

Keyword(s):

Botulinum Neurotoxin ◽

Type A ◽

Preliminary Results ◽

Botulinum Neurotoxin Type A

Download Full-text

Faculty Opinions recommendation of Botulinum neurotoxin type A is internalized and translocated from small synaptic vesicles at the neuromuscular junction.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717988167.793477443 ◽

2013 ◽

Author(s):

Patrick McNutt ◽

Ian Gut

Keyword(s):

Neuromuscular Junction ◽

Synaptic Vesicles ◽

Botulinum Neurotoxin ◽

Type A ◽

Botulinum Neurotoxin Type A

Download Full-text

OnabotulinumtoxinA exhibits greater efficacy compared to purified botulinum neurotoxin type A (BoNT/A-150 kDa) in peripheral pain models

Toxicon ◽

10.1016/j.toxicon.2020.11.490 ◽

2021 ◽

Vol 190 ◽

pp. S70

Author(s):

Sudhakar R. Subramaniam ◽

Greg Nicholson ◽

Brian B. Cai ◽

Amy D. Brideau-Andersen ◽

Ron S. Broide

Keyword(s):

Botulinum Neurotoxin ◽

Type A ◽

Botulinum Neurotoxin Type A ◽

Pain Models ◽

Peripheral Pain

Download Full-text

Not only gustatory sweating and flushing: Signs and symptoms associated with Frey's syndrome and the role of botulinum neurotoxin type A therapy

Toxicon ◽

10.1016/j.toxicon.2020.11.437 ◽

2021 ◽

Vol 190 ◽

pp. S46-S47

Author(s):

Maria Raffaella Marchese ◽

Giovanni Almadori

Keyword(s):

Botulinum Neurotoxin ◽

Signs And Symptoms ◽

Type A ◽

Frey’S Syndrome ◽

Botulinum Neurotoxin Type A ◽

Gustatory Sweating ◽

Frey's Syndrome

Download Full-text

Real-world treatment intervals with botulinum neurotoxin type A in poststroke spasticity management—Are different formulations different?

Toxicon ◽

10.1016/j.toxicon.2020.11.475 ◽

2021 ◽

Vol 190 ◽

pp. S63

Author(s):

Susana Rosa ◽

Bruno Guimarães ◽

Joana Martins ◽

José Luís Mesquita ◽

Margarida Freitas ◽

...

Keyword(s):

Botulinum Neurotoxin ◽

Type A ◽

Botulinum Neurotoxin Type A

Download Full-text